4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-032404
President & Immunovant CEO sold 100,000 shares at $11.72 ($1,172,000)
- President & Immunovant CEO acquired 100,000 shares (option exercise)
- President & Immunovant CEO gave up 7,051 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric President & Immunovant CEO | 2025-08-20 | Shares withheld for taxes 10b5-1 | −7,051 | $11.72 | $82,638 | 1,653,585 | D: show line 1 in the form |
| Venker Eric President & Immunovant CEO | 2025-08-20 | Option exercise 10b5-1 | +100,000 | $3.85 | $385,000 | 1,753,585 | D: show line 2 in the form |
| Venker Eric President & Immunovant CEO | 2025-08-20 | Sale 10b5-1 | −100,000 | $11.72 | $1,172,000 | 1,653,585 | D: show line 3 in the form |
| Open-market sales · 100,000 sh · avg $11.72 · $1,172,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric President & Immunovant CEO | 2025-08-20 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100,000 | 8,038,897 | D: show line 4 in the form |
Loading xslF345X05/form4.xml…